February 19, 2026 11:26 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
PM Modi warns ‘AI must not control humans’ as India unveils bold tech vision at AI Impact Summit 2026 | Former South Korean President Yoon Suk Yeol sentenced to life over failed martial law bid | Tata Group joins hands with OpenAI in massive AI push to transform India and global industries | Epstein Files row: Bill Gates to skip keynote address at AI Summit 2026 | AI Impact Summit: Google launches game-changing America-India Connect plan with $15 billion backing | AI takes centre stage as Modi meets Google CEO Sundar Pichai in Delhi | G7 Spotlight: Emmanuel Macron invites Narendra Modi for 2026 Summit | AI Summit embarrassment! Galgotias University asked to vacate stall after ‘own robot’ exposed as China’s Unitree Go2 | Actor Rajpal Yadav granted interim bail in ₹9-crore cheque bounce case | Learn AI or become redundant: Microsoft India President issues stark message
Covishield
Image tweeted by @adarpoonawalla

Covishield ready to roll out in coming weeks: SII CEO Adar Poonawalla

| @indiablooms | Jan 03, 2021, at 09:11 pm

New Delhi/UNI: Hours after the Drugs Controller General of India (DGCI) approved Oxford-AstraZeneca COVID-19 vaccine ''Covishield'' for restricted emergency use, Serum Institute of India (SII) CEO Adar Poonawalla announced that the vaccine is ready to roll out in the coming weeks.

"Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks," Poonawalla tweeted.

He further expressed gratitude to Prime Minister Narendra Modi and Union Health Minister Dr HarshVardhan, among others for extending their support.

"Thank you Hon. Sri @narendramodi Ji, Hon. Sri @drharshvardhan Ji, @MoHFW_INDIA @ICMRDELHI @DBTIndia #DCGI_India @UniofOxford @AstraZeneca @gavi @GaviSeth @gatesfoundation and @BillGates for your support," Poonawalla said.

The pharmaceutical giant had on December 7 sought an emergency use authorisation for its Covishield coronavirus vaccine from the Drugs Controller General of India.

Experts say the Covishield vaccine is logistically feasible for distribution in urban and rural parts as it can be stored at two to eight degrees Celsius, which is an ideal temperature for being kept in cold storages in the country.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.